PRESS RELEASE NMD Pharma Moves Corporate Headquarters to INCUBA to Support Future Growth
NMD Pharma treats first patient with the firm's most promising drug candidate
Management — NMD Pharma
NMD Pharma - PIR International
News: Pressemeddelelse fra INCUBA: Biotek-kometen NMD Pharma fortsætter vækstrejse i Aarhus - Biopeople
NMD Pharma to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Biopeople Newsletter January 2020 - Biopeople
NMD Pharma A/S | LinkedIn
NMD Pharma Information | NMD Pharma Profile
NMD Pharma A/S | LinkedIn
NMD Pharma - PIR International
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders
NMD Pharma - Inkef capital
NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn
NMD Pharma
NMD Pharma to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
News: Brew your own in Aarhus in March - Biopeople
Biotech completes financing round to advance neuromuscular treatments - EPM Magazine
NMD Pharma A/S | LinkedIn
Management — NMD Pharma
Katja Krustrup Pedersen - Research Scientist and Project Manager - NMD Pharma | LinkedIn
